Business Description
Lisata Therapeutics is a New Jersey-based company focused on developing new treatments for patients with solid tumor cancers. Its lead drug candidate, certepetide, is currently being tested in Phase 2 clinical trials alongside existing cancer treatments, targeting difficult-to-treat cancers including pancreatic, colon, and bile duct cancers, as well as brain tumors. The company has been operating for over four decades and has not yet brought a product to market.
